KiraGen Bio Joins LabCentral & C10 Labs’ Inaugural AI BioHub to Accelerate AI-Driven Cell Therapy
- Aaron Edwards
- Jul 12
- 1 min read
We’re thrilled to share that KiraGen Bio has been selected to join the inaugural cohort of the new AI BioHub, a bold initiative from LabCentral and C10 Labs at the heart of Kendall Square.
Backed by a $1.9M grant from MassTech, this program is designed to close the gap between AI’s promise and experimental reality—exactly where KiraGen thrives.
At KiraGen, we’re engineering multiplex-edited CAR-T therapies to overcome the suppressive tumor microenvironment in solid tumors. The KiraLOGIC platform integrates wet-lab data and AI to rationally design these edits—making this AI-first accelerator a perfect fit for our mission.
As part of the AI BioHub, we’ll gain:
Access to cutting-edge wet lab + compute infrastructure
A curated community of AI-native biotech entrepreneurs
Hands-on support from leaders like Anna Marie Wagner and Shahid Azim
Entrepreneurial programming and investor access to scale our impact
This isn’t just an accelerator. It’s a launchpad for the next generation of AI-biology companies—and we’re honored to be part of it.
Stay tuned as we put AI in the loop of drug discovery.
🔗 Learn more about the AI BioHub: https://www.labcentral.org/startup-support/ai-biohub
🔗 Read the official press release: https://www.labcentral.org/events-and-media/press-releases/labcentral-and-c10-labs-unveil-new-ai-biohub-in-kendall-square
